IBDEI0NA ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11089,1,3,0)
 ;;=3^Individual Counseling per 15 min
 ;;^UTILITY(U,$J,358.3,11090,0)
 ;;=H0005^^48^624^3^^^^1
 ;;^UTILITY(U,$J,358.3,11090,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11090,1,2,0)
 ;;=2^H0005
 ;;^UTILITY(U,$J,358.3,11090,1,3,0)
 ;;=3^Addictions Group
 ;;^UTILITY(U,$J,358.3,11091,0)
 ;;=H0006^^48^624^5^^^^1
 ;;^UTILITY(U,$J,358.3,11091,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11091,1,2,0)
 ;;=2^H0006
 ;;^UTILITY(U,$J,358.3,11091,1,3,0)
 ;;=3^Alcohol/Drug Case Management
 ;;^UTILITY(U,$J,358.3,11092,0)
 ;;=H0020^^48^624^8^^^^1
 ;;^UTILITY(U,$J,358.3,11092,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11092,1,2,0)
 ;;=2^H0020
 ;;^UTILITY(U,$J,358.3,11092,1,3,0)
 ;;=3^Methadone Administration
 ;;^UTILITY(U,$J,358.3,11093,0)
 ;;=H0025^^48^624^2^^^^1
 ;;^UTILITY(U,$J,358.3,11093,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11093,1,2,0)
 ;;=2^H0025
 ;;^UTILITY(U,$J,358.3,11093,1,3,0)
 ;;=3^Addictions Education Service
 ;;^UTILITY(U,$J,358.3,11094,0)
 ;;=H0030^^48^624^4^^^^1
 ;;^UTILITY(U,$J,358.3,11094,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11094,1,2,0)
 ;;=2^H0030
 ;;^UTILITY(U,$J,358.3,11094,1,3,0)
 ;;=3^Addictions Hotline Services
 ;;^UTILITY(U,$J,358.3,11095,0)
 ;;=99600^^48^625^1^^^^1
 ;;^UTILITY(U,$J,358.3,11095,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11095,1,2,0)
 ;;=2^99600
 ;;^UTILITY(U,$J,358.3,11095,1,3,0)
 ;;=3^Case Management at Pts Home
 ;;^UTILITY(U,$J,358.3,11096,0)
 ;;=T1016^^48^625^2^^^^1
 ;;^UTILITY(U,$J,358.3,11096,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11096,1,2,0)
 ;;=2^T1016
 ;;^UTILITY(U,$J,358.3,11096,1,3,0)
 ;;=3^Case Management per 15min
 ;;^UTILITY(U,$J,358.3,11097,0)
 ;;=96372^^48^626^1^^^^1
 ;;^UTILITY(U,$J,358.3,11097,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11097,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,11097,1,3,0)
 ;;=3^Ther/Proph/Diag Inj SC/IM
 ;;^UTILITY(U,$J,358.3,11098,0)
 ;;=96374^^48^626^2^^^^1
 ;;^UTILITY(U,$J,358.3,11098,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11098,1,2,0)
 ;;=2^96374
 ;;^UTILITY(U,$J,358.3,11098,1,3,0)
 ;;=3^Ther/Proph/Diag Inj IV Push
 ;;^UTILITY(U,$J,358.3,11099,0)
 ;;=96376^^48^626^3^^^^1
 ;;^UTILITY(U,$J,358.3,11099,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11099,1,2,0)
 ;;=2^96376
 ;;^UTILITY(U,$J,358.3,11099,1,3,0)
 ;;=3^Tx/Pro/Dx Inj Same Drug-Add-on
 ;;^UTILITY(U,$J,358.3,11100,0)
 ;;=J2680^^48^627^1^^^^1
 ;;^UTILITY(U,$J,358.3,11100,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11100,1,2,0)
 ;;=2^J2680
 ;;^UTILITY(U,$J,358.3,11100,1,3,0)
 ;;=3^Fluphenazine Decanoate 25mg
 ;;^UTILITY(U,$J,358.3,11101,0)
 ;;=J1631^^48^627^2^^^^1
 ;;^UTILITY(U,$J,358.3,11101,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11101,1,2,0)
 ;;=2^J1631
 ;;^UTILITY(U,$J,358.3,11101,1,3,0)
 ;;=3^Haloperidol Decanoate per 50mg
 ;;^UTILITY(U,$J,358.3,11102,0)
 ;;=J2315^^48^627^3^^^^1
 ;;^UTILITY(U,$J,358.3,11102,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11102,1,2,0)
 ;;=2^J2315
 ;;^UTILITY(U,$J,358.3,11102,1,3,0)
 ;;=3^Naltrexone,Depot Form 1mg
 ;;^UTILITY(U,$J,358.3,11103,0)
 ;;=J2426^^48^627^8^^^^1
 ;;^UTILITY(U,$J,358.3,11103,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11103,1,2,0)
 ;;=2^J2426
 ;;^UTILITY(U,$J,358.3,11103,1,3,0)
 ;;=3^Paliperidone Palmitate 234mg/kit
 ;;^UTILITY(U,$J,358.3,11104,0)
 ;;=J2426^^48^627^7^^^^1
 ;;^UTILITY(U,$J,358.3,11104,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,11104,1,2,0)
 ;;=2^J2426
 ;;^UTILITY(U,$J,358.3,11104,1,3,0)
 ;;=3^Paliperidone Palmitate 156mg/kit
 ;;^UTILITY(U,$J,358.3,11105,0)
 ;;=J2426^^48^627^6^^^^1
 ;;^UTILITY(U,$J,358.3,11105,1,0)
 ;;=^358.31IA^3^2
 ;;
 ;;$END ROU IBDEI0NA
